Mematen 5 Tablet contains Memantine Hydrochloride USP 5mg, an NMDA receptor antagonist prescribed for the management of mild to moderate Alzheimer’s disease. It regulates glutamate levels in the brain to support cognitive function and help reduce symptoms like memory loss, confusion, and behavioral disturbances.
This medicine belongs to the neurology and CNS segment and is an essential option for patients in the early stages of cognitive decline. Its low-dose formulation allows for gradual titration, improving patient tolerance and minimizing side effects.
Mematen 5 Tablet supports daily cognitive performance and enhances patient quality of life. It is widely used in hospitals, neurology clinics, and geriatric care centers due to its proven clinical efficacy.
For PCD pharma franchise partners, wholesalers, exporters, and third-party manufacturers, Mematen 5 Tablet provides a profitable B2B opportunity in the Alzheimer’s treatment segment, with steady demand and strong growth potential across India.